25021-408Level 3
eptifibatide (eptifibatide)
**Product type:** Human Prescription Drug
**Active ingredient:** EPTIFIBATIDE
**Strength:** .75 mg/mL
**Dosage form:** Injection, Solution
**Route:** Intravenous
**Labeler:** Sagent Pharmaceuticals
**Marketing category:** ANDA (ANDA204693)
**Pharmacologic class:** Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC]
GET
/api/v1/systems/ndc_fda/nodes/25021-408Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.